Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs

MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the perfo...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Scientific reports Ročník 7; číslo 1; s. 7725 - 14
Hlavní autori: Garcia-Elias, Anna, Alloza, Leonor, Puigdecanet, Eulàlia, Nonell, Lara, Tajes, Marta, Curado, Joao, Enjuanes, Cristina, Díaz, Oscar, Bruguera, Jordi, Martí-Almor, Julio, Comín-Colet, Josep, Benito, Begoña
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London Nature Publishing Group UK 10.08.2017
Nature Publishing Group
Nature Portfolio
Predmet:
ISSN:2045-2322, 2045-2322
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite ® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit ® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
AbstractList MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite ® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit ® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
Abstract MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.
ArticleNumber 7725
Author Puigdecanet, Eulàlia
Bruguera, Jordi
Nonell, Lara
Tajes, Marta
Comín-Colet, Josep
Curado, Joao
Benito, Begoña
Alloza, Leonor
Enjuanes, Cristina
Martí-Almor, Julio
Díaz, Oscar
Garcia-Elias, Anna
Author_xml – sequence: 1
  givenname: Anna
  orcidid: 0000-0002-6609-6119
  surname: Garcia-Elias
  fullname: Garcia-Elias, Anna
  email: agarciaelias@imim.es
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 2
  givenname: Leonor
  surname: Alloza
  fullname: Alloza, Leonor
  organization: Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 3
  givenname: Eulàlia
  surname: Puigdecanet
  fullname: Puigdecanet, Eulàlia
  organization: Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 4
  givenname: Lara
  surname: Nonell
  fullname: Nonell, Lara
  organization: Microarray Analysis Service, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 5
  givenname: Marta
  surname: Tajes
  fullname: Tajes, Marta
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 6
  givenname: Joao
  surname: Curado
  fullname: Curado, Joao
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra
– sequence: 7
  givenname: Cristina
  surname: Enjuanes
  fullname: Enjuanes, Cristina
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Cardiology Department, Hospital del Mar
– sequence: 8
  givenname: Oscar
  surname: Díaz
  fullname: Díaz, Oscar
  organization: Cardiovascular Risk and Nutrition Group, IMIM (Hospital del Mar Medical Research Institute)
– sequence: 9
  givenname: Jordi
  surname: Bruguera
  fullname: Bruguera, Jordi
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Cardiology Department, Hospital del Mar
– sequence: 10
  givenname: Julio
  surname: Martí-Almor
  fullname: Martí-Almor, Julio
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Cardiology Department, Hospital del Mar
– sequence: 11
  givenname: Josep
  surname: Comín-Colet
  fullname: Comín-Colet, Josep
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Cardiology Department, Hospital del Mar
– sequence: 12
  givenname: Begoña
  surname: Benito
  fullname: Benito, Begoña
  organization: Group of Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), Cardiology Department, Hospital del Mar
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28798363$$D View this record in MEDLINE/PubMed
BookMark eNp9kl2L1DAUhousuB_uH_BCCt54U81nm9wIy-rqwqIgeh3S9HQmQ5vMJunC7K83Mx2H2QUtlCTt-7zn9PQ9L06cd1AUbzD6gBEVHyPDXIoK4aZCAlNW0RfFGUGMV4QScnK0Py0uY1yhfHEiGZavilMiGiloTc8K9xl666xblPeTdsn21uhkvStHSEvfxVK7rvTrZEf7uFWtg0_e-CGWvQ_laE3wOgS9KZebNtjOPs6070tjg5mGfMzUTvfz-1V8Xbzs9RDhcr9eFL9vvvy6_lbd_fh6e311VxkuSKoYN5SyjuoOcYQxErUhnNUcI2koyJoRjbqWQ4-k7GrgvSSagu5rgIZSWdOL4nb27bxeqXWwow4b5bVVuwc-LJQOyZoBVMuAciqN0G3DDDJaMNETTEwuoVuhs9en2Ws9tSN0BlwKenhi-vSNs0u18A-Kc04axLIBng1MnIwKYCDkIe_Aw2F7E9QQRfPPrXlm3u-LBn8_QUxqtNHAMGgHfooKSyI4kpzgLH33TLryU3B5vFnFG9zIvGTV2-OvOLT_NwpZQPZdBh9jgP4gwUhtI6fmyKkcObWLnNpC4hlkbNpFIE_CDv9H6YzGXMctIBy1_W_qD7SX7Fs
CitedBy_id crossref_primary_10_1038_s41598_020_57659_7
crossref_primary_10_1016_j_jcms_2024_03_030
crossref_primary_10_1016_j_rbmo_2020_02_002
crossref_primary_10_1016_j_envpol_2025_126914
crossref_primary_10_1016_j_lwt_2019_02_028
crossref_primary_10_1128_JB_00017_21
crossref_primary_10_3390_jcm9041139
crossref_primary_10_1186_s12967_018_1592_6
crossref_primary_10_1155_2018_6380463
crossref_primary_10_23736_S0393_0564_25_00034_2
crossref_primary_10_1038_s42004_023_00872_y
crossref_primary_10_1016_j_bj_2024_100769
crossref_primary_10_1016_j_ab_2020_113898
crossref_primary_10_3390_cancers13205060
crossref_primary_10_1177_00045632221129778
crossref_primary_10_1016_j_forsciint_2024_111930
crossref_primary_10_3390_biomedicines12102393
crossref_primary_10_1080_19396368_2021_1912851
crossref_primary_10_1111_vcp_12743
crossref_primary_10_3233_CBM_201600
crossref_primary_10_3390_pharmaceutics14071482
crossref_primary_10_1007_s11033_022_07170_1
crossref_primary_10_1016_j_urolonc_2018_09_006
crossref_primary_10_1016_j_ynpai_2025_100191
crossref_primary_10_3390_genes13020328
crossref_primary_10_1371_journal_pone_0219311
crossref_primary_10_1002_bab_1699
crossref_primary_10_3389_fonc_2020_00619
crossref_primary_10_1016_j_jep_2024_117963
crossref_primary_10_3390_cancers12061445
crossref_primary_10_3390_ncrna11010011
crossref_primary_10_1016_j_fsigen_2023_102910
crossref_primary_10_1515_cclm_2018_0838
crossref_primary_10_1128_spectrum_02425_23
crossref_primary_10_1016_j_abb_2020_108583
crossref_primary_10_3390_ani15020200
crossref_primary_10_3390_ijms221910377
crossref_primary_10_3389_fonc_2021_691915
crossref_primary_10_1186_s12938_021_00857_9
crossref_primary_10_1038_s41598_020_66072_z
crossref_primary_10_1155_2020_8896738
crossref_primary_10_1186_s12864_022_08464_1
crossref_primary_10_1016_j_omtn_2024_102262
crossref_primary_10_1124_jpet_121_000896
crossref_primary_10_3390_cancers13133348
Cites_doi 10.1016/j.ab.2012.09.007
10.1016/j.ab.2014.08.006
10.1146/annurev-biochem-060308-103103
10.1016/j.ymeth.2010.01.032
10.1016/j.cell.2009.01.002
10.1186/1471-2164-12-435
10.1186/1471-2164-15-395
10.1016/j.cell.2004.12.035
10.1073/pnas.0804549105
10.1161/CIRCRESAHA.111.247452
10.1016/j.ymeth.2012.09.015
10.1016/j.addr.2014.09.001
10.1371/journal.pone.0020769
10.1038/nrclinonc.2011.76
10.1038/nrg3198
10.1371/journal.pone.0082753
10.3390/molecules19021568
10.1038/nmeth.3014
10.1371/journal.pone.0041561
10.1261/rna.036863.112
10.1186/s12867-015-0039-3
10.1038/srep19529
10.1111/jcmm.12236
10.1371/journal.pone.0064795
10.1097/PDM.0b013e318269de3b
10.1373/clinchem.2009.141580
10.1007/s00216-015-8846-4
10.1373/clinchem.2014.221341
10.1007/s11684-014-0379-2
ContentType Journal Article
Contributor Universitat de Barcelona
Contributor_xml – sequence: 1
  fullname: Universitat de Barcelona
Copyright The Author(s) 2017
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
cc-by (c) Garcia-Elias, Anna et al., 2017 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es
Copyright_xml – notice: The Author(s) 2017
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: cc-by (c) Garcia-Elias, Anna et al., 2017 info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/3.0/es">http://creativecommons.org/licenses/by/3.0/es</a>
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
XX2
5PM
DOA
DOI 10.1038/s41598-017-08134-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database (ProQuest)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Recercat
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE - Academic
MEDLINE
CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 14
ExternalDocumentID oai_doaj_org_article_b4e3539c8ab74c0ca848f212ca0dab8a
PMC5552704
oai_recercat_cat_2072_303865
28798363
10_1038_s41598_017_08134_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
XX2
5PM
ID FETCH-LOGICAL-c582t-45c334d3ad05011086c25465109c3e9642a0db5ef099d6e5f92a3eaf6ee733963
IEDL.DBID BENPR
ISICitedReferencesCount 52
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000407400100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Mon Nov 17 00:51:08 EST 2025
Tue Nov 04 01:58:22 EST 2025
Fri Nov 07 13:34:20 EST 2025
Thu Oct 02 07:02:00 EDT 2025
Tue Oct 07 07:35:41 EDT 2025
Thu Apr 03 06:51:00 EDT 2025
Sat Nov 29 02:49:26 EST 2025
Tue Nov 18 22:20:26 EST 2025
Fri Feb 21 02:39:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c582t-45c334d3ad05011086c25465109c3e9642a0db5ef099d6e5f92a3eaf6ee733963
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6609-6119
OpenAccessLink https://www.proquest.com/docview/1957179195?pq-origsite=%requestingapplication%
PMID 28798363
PQID 1957179195
PQPubID 2041939
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_b4e3539c8ab74c0ca848f212ca0dab8a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5552704
csuc_recercat_oai_recercat_cat_2072_303865
proquest_miscellaneous_1928509521
proquest_journals_1957179195
pubmed_primary_28798363
crossref_primary_10_1038_s41598_017_08134_3
crossref_citationtrail_10_1038_s41598_017_08134_3
springer_journals_10_1038_s41598_017_08134_3
PublicationCentury 2000
PublicationDate 2017-08-10
PublicationDateYYYYMMDD 2017-08-10
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-10
  day: 10
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Jensen (CR14) 2011; 12
Wang (CR21) 2012; 7
CR19
CR17
Ge (CR29) 2014; 19
Jung (CR13) 2010; 56
Cortez (CR8) 2011; 8
Cheng (CR16) 2015; 81C
Deben (CR24) 2013; 22
Lewis, Burge, Bartel (CR3) 2005; 120
Moret (CR22) 2013; 8
Monleau (CR20) 2014; 15
Duttagupta, Jiang, Gollub, Getts, Jones (CR12) 2011; 6
Li, Bn-Dov, Mauro, Williams (CR27) 2015; 16
Bartel (CR1) 2009; 136
Pritchard, Cheng, Tewari (CR25) 2012; 13
Lee, Cheung, Leung (CR26) 2014; 465
Blondal (CR4) 2013; 59
Moldovan (CR6) 2014; 18
CR28
Creemers, Tijsen, Pinto (CR10) 2012; 110
Burgos (CR9) 2013; 19
El-Khoury, Pierson, Kaoma, Bernardin, Berchem (CR23) 2016; 6
Fabian, Sonenberg, Filipowicz (CR2) 2010; 79
Mitchell (CR11) 2008; 105
Kroh, Parkin, Mitchell, Tewari (CR7) 2010; 50
Cheng (CR18) 2013; 8
Mestdagh (CR15) 2014; 11
Li, Kowdley (CR5) 2012; 431
KL Burgos (8134_CR9) 2013; 19
PS Mitchell (8134_CR11) 2008; 105
K Wang (8134_CR21) 2012; 7
V El-Khoury (8134_CR23) 2016; 6
CC Pritchard (8134_CR25) 2012; 13
BP Lewis (8134_CR3) 2005; 120
M Jung (8134_CR13) 2010; 56
I Moret (8134_CR22) 2013; 8
R Duttagupta (8134_CR12) 2011; 6
P Mestdagh (8134_CR15) 2014; 11
M Monleau (8134_CR20) 2014; 15
8134_CR19
G Cheng (8134_CR16) 2015; 81C
8134_CR17
DP Bartel (8134_CR1) 2009; 136
X Li (8134_CR27) 2015; 16
MR Fabian (8134_CR2) 2010; 79
EE Creemers (8134_CR10) 2012; 110
Q Ge (8134_CR29) 2014; 19
L Moldovan (8134_CR6) 2014; 18
JTY Lee (8134_CR26) 2014; 465
SG Jensen (8134_CR14) 2011; 12
T Blondal (8134_CR4) 2013; 59
MA Cortez (8134_CR8) 2011; 8
Y Li (8134_CR5) 2012; 431
C Deben (8134_CR24) 2013; 22
HH Cheng (8134_CR18) 2013; 8
8134_CR28
EM Kroh (8134_CR7) 2010; 50
References_xml – volume: 431
  start-page: 69
  year: 2012
  end-page: 75
  ident: CR5
  article-title: Method for microRNA isolation from clinical serum samples
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2012.09.007
– volume: 465
  start-page: 179
  year: 2014
  end-page: 86
  ident: CR26
  article-title: Correction for concentration overestimation of nucleic acids with phenol
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2014.08.006
– volume: 79
  start-page: 351
  year: 2010
  end-page: 79
  ident: CR2
  article-title: Regulation of mRNA translation and stability by microRNAs
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev-biochem-060308-103103
– volume: 50
  start-page: 298
  year: 2010
  end-page: 301
  ident: CR7
  article-title: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
  publication-title: Methods
  doi: 10.1016/j.ymeth.2010.01.032
– volume: 136
  start-page: 215
  year: 2009
  end-page: 33
  ident: CR1
  article-title: MicroRNAs: target recognition and regulatory functions
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.002
– volume: 12
  start-page: 435
  year: 2011
  ident: CR14
  article-title: Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-12-435
– volume: 15
  start-page: 395
  year: 2014
  ident: CR20
  article-title: Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-15-395
– volume: 120
  start-page: 15
  year: 2005
  end-page: 20
  ident: CR3
  article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.035
– volume: 105
  start-page: 10513
  year: 2008
  end-page: 8
  ident: CR11
  article-title: Circulating microRNAs as stable blood-based markers for cancer detection
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0804549105
– volume: 110
  start-page: 483
  year: 2012
  end-page: 95
  ident: CR10
  article-title: Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.111.247452
– volume: 59
  start-page: 164
  year: 2013
  end-page: 169
  ident: CR4
  article-title: Assessing sample and miRNA profile quality in serum and plasma or other biofluids
  publication-title: Methods
  doi: 10.1016/j.ymeth.2012.09.015
– volume: 81C
  start-page: 75
  year: 2015
  end-page: 93
  ident: CR16
  article-title: Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2014.09.001
– volume: 6
  start-page: e20769
  year: 2011
  ident: CR12
  article-title: Impact of cellular miRNAs on circulating miRNA biomarker signatures
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0020769
– volume: 8
  start-page: 467
  year: 2011
  end-page: 77
  ident: CR8
  article-title: MicroRNAs in body fluids–the mix of hormones and biomarkers
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2011.76
– volume: 13
  start-page: 358
  year: 2012
  end-page: 369
  ident: CR25
  article-title: MicroRNA profiling: approaches and considerations
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3198
– ident: CR19
– volume: 8
  start-page: e82753
  year: 2013
  ident: CR22
  article-title: Assessing an improved protocol for plasma microRNA extraction
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0082753
– volume: 19
  start-page: 1568
  year: 2014
  end-page: 1575
  ident: CR29
  article-title: MiRNA in plasma exosome is stable under different storage conditions
  publication-title: Molecules
  doi: 10.3390/molecules19021568
– ident: CR17
– volume: 11
  start-page: 809
  year: 2014
  end-page: 815
  ident: CR15
  article-title: Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3014
– volume: 7
  start-page: e41561
  year: 2012
  ident: CR21
  article-title: Comparing the MicroRNA spectrum between serum and plasma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0041561
– volume: 19
  start-page: 712
  year: 2013
  end-page: 22
  ident: CR9
  article-title: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing
  publication-title: RNA
  doi: 10.1261/rna.036863.112
– volume: 16
  start-page: 9
  year: 2015
  ident: CR27
  article-title: Lwering the quantification limit of the QubitTM RNA HS Assay using RNA spike-in
  publication-title: BMC Mol. Biol.
  doi: 10.1186/s12867-015-0039-3
– volume: 6
  start-page: 19529
  year: 2016
  ident: CR23
  article-title: Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material
  publication-title: Sci. Rep.
  doi: 10.1038/srep19529
– volume: 18
  start-page: 371
  year: 2014
  end-page: 90
  ident: CR6
  article-title: Methodological challenges in utilizing miRNAs as circulating biomarkers
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.12236
– ident: CR28
– volume: 8
  start-page: e64795
  year: 2013
  ident: CR18
  article-title: Plasma processing conditions substantially influence circulating microRNA biomarker levels
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0064795
– volume: 22
  start-page: 59
  year: 2013
  end-page: 64
  ident: CR24
  article-title: Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples
  publication-title: Diagn. Mol. Pathol.
  doi: 10.1097/PDM.0b013e318269de3b
– volume: 56
  start-page: 998
  year: 2010
  end-page: 1006
  ident: CR13
  article-title: Robust microRNA stability in degraded RNA preparations from human tissue and cell samples
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2009.141580
– volume: 110
  start-page: 483
  year: 2012
  ident: 8134_CR10
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.111.247452
– ident: 8134_CR28
  doi: 10.1007/s00216-015-8846-4
– volume: 465
  start-page: 179
  year: 2014
  ident: 8134_CR26
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2014.08.006
– volume: 50
  start-page: 298
  year: 2010
  ident: 8134_CR7
  publication-title: Methods
  doi: 10.1016/j.ymeth.2010.01.032
– volume: 19
  start-page: 1568
  year: 2014
  ident: 8134_CR29
  publication-title: Molecules
  doi: 10.3390/molecules19021568
– volume: 11
  start-page: 809
  year: 2014
  ident: 8134_CR15
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3014
– volume: 431
  start-page: 69
  year: 2012
  ident: 8134_CR5
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2012.09.007
– volume: 15
  start-page: 395
  year: 2014
  ident: 8134_CR20
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-15-395
– volume: 16
  start-page: 9
  year: 2015
  ident: 8134_CR27
  publication-title: BMC Mol. Biol.
  doi: 10.1186/s12867-015-0039-3
– volume: 19
  start-page: 712
  year: 2013
  ident: 8134_CR9
  publication-title: RNA
  doi: 10.1261/rna.036863.112
– volume: 12
  start-page: 435
  year: 2011
  ident: 8134_CR14
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-12-435
– ident: 8134_CR19
  doi: 10.1373/clinchem.2014.221341
– ident: 8134_CR17
  doi: 10.1007/s11684-014-0379-2
– volume: 13
  start-page: 358
  year: 2012
  ident: 8134_CR25
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3198
– volume: 18
  start-page: 371
  year: 2014
  ident: 8134_CR6
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.12236
– volume: 22
  start-page: 59
  year: 2013
  ident: 8134_CR24
  publication-title: Diagn. Mol. Pathol.
  doi: 10.1097/PDM.0b013e318269de3b
– volume: 136
  start-page: 215
  year: 2009
  ident: 8134_CR1
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.002
– volume: 59
  start-page: 164
  year: 2013
  ident: 8134_CR4
  publication-title: Methods
  doi: 10.1016/j.ymeth.2012.09.015
– volume: 105
  start-page: 10513
  year: 2008
  ident: 8134_CR11
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0804549105
– volume: 6
  start-page: e20769
  year: 2011
  ident: 8134_CR12
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0020769
– volume: 8
  start-page: e64795
  year: 2013
  ident: 8134_CR18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0064795
– volume: 8
  start-page: 467
  year: 2011
  ident: 8134_CR8
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2011.76
– volume: 79
  start-page: 351
  year: 2010
  ident: 8134_CR2
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev-biochem-060308-103103
– volume: 7
  start-page: e41561
  year: 2012
  ident: 8134_CR21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0041561
– volume: 81C
  start-page: 75
  year: 2015
  ident: 8134_CR16
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2014.09.001
– volume: 120
  start-page: 15
  year: 2005
  ident: 8134_CR3
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.035
– volume: 6
  start-page: 19529
  year: 2016
  ident: 8134_CR23
  publication-title: Sci. Rep.
  doi: 10.1038/srep19529
– volume: 56
  start-page: 998
  year: 2010
  ident: 8134_CR13
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2009.141580
– volume: 8
  start-page: e82753
  year: 2013
  ident: 8134_CR22
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0082753
SSID ssj0000529419
Score 2.4376898
Snippet MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low...
Abstract MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very...
SourceID doaj
pubmedcentral
csuc
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7725
SubjectTerms 38/39
38/47
38/61
38/90
45
631/1647/2217/748
692/53/2423
Biochemical markers
Biomarkers
Blood plasma
Circulating MicroRNA
Computational Biology - methods
Contaminants
Expressió gènica
Gene expression
Gene Expression Profiling - instrumentation
Gene Expression Profiling - methods
Humanities and Social Sciences
Humans
Hybridization
Marcadors bioquímics
Medical protocols
Micro RNAs
MicroRNAs
miRNA
multidisciplinary
Nucleic Acid Hybridization - methods
Plasma
Plasma sanguini
Protocols clínics
Reproducibility of Results
Science
Science (multidisciplinary)
Spectrophotometers
Transcriptome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLbQCCQuiLKmFGQkTkDUjJfYPpal4oBGCAHqzbIdWx2JJjSZQRp-fZ_tTDTDeuGQQ5KXxHmL32fZ_h5Cz8KccR-aujSWupLR4EopDYR7ZYSklrgmcel9eS8WC3l2pj7slPqKa8IyPXBW3LFlnnKqnDRWMFc5I5kM0N86UzXGygSNAPXsDKYyqzdRbK7GXTIVlccDZKq4mww6ZciClJV0LxPN3LB2I2__78Dmr2smf5o4Tfno9Da6NQJJfJJ_4ABd8-0ddCOXltzcRe0bH1LtB3y5NnlBULIBziWjB2zaBnfQX1wsf0SpyNfQgVMMGFAsvojL9Ezfmw0-38Q9XeNuTdwF7Ja9SzW_4Kkk93FxMtxDn0_ffnr9rhxrK5SOS7IqGXeUsoaapuIRAsjakVQXvVKOegWjEtCvBTMCgmxqz4MihnoTau8FpRC199Gs7Vr_EGGrbBCEe0kAStaSGAfiHOAwMz4IGwo03-pZu5F4PNa_-KrTBDiVOttGg210so2mBXoxPfMt0278Vfp5NJ-GHOF70KaOnNnTSTxIJYiGbC1rXqBX0cjTa6NsugBep0ev0__yugIdbV1Ej0E_6LniIrK9KvjG0-k2hGucgzGt79ZRhkjAaACaCvQge9TUEhi8Kklr-B2x52t7Td2_0y7PEyU4j0R6FSvQy61X7jTrj3o7_B-qeIRukhxVkNKP0GzVr_1jdN19Xy2H_kkKyys1pD1v
  priority: 102
  providerName: Directory of Open Access Journals
Title Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs
URI https://link.springer.com/article/10.1038/s41598-017-08134-3
https://www.ncbi.nlm.nih.gov/pubmed/28798363
https://www.proquest.com/docview/1957179195
https://www.proquest.com/docview/1928509521
https://recercat.cat/handle/2072/303865
https://pubmed.ncbi.nlm.nih.gov/PMC5552704
https://doaj.org/article/b4e3539c8ab74c0ca848f212ca0dab8a
Volume 7
WOSCitedRecordID wos000407400100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZYCxIv3C-BURmJJyBa6kvsPKENNoHEqmgCVJ4sx3FYJZZsSYtUfj3Hjhsol73wEEtpTirb5_bFxz4HoWfVlHFblWmsC2piRisTS6lB3RMtJC2IKX0uvU_vxWwm5_MsDwtuXdhWubGJ3lCXjXFr5HvTjAuXSjPjr84vYlc1ykVXQwmNHTR2mcrYCI0PDmf5ybDK4uJYbJqF0zIJlXsdeCx3qgyMM3hDymK65ZFGpluZkL__b6Dzz72TvwVQvV86uvm_I7qFbgREivd7EbqNrtj6DrrW16hc30X1G1v5IhL4YqX7nUWembivPd1hXZe4AcNztvjuqFzihwakq8MAh_GZ2--n21av8enaHQ4Lxz5xU2GzaI0vHgZvebqT2X53D308Ovzw-m0cijTEhkuyjBk3lLKS6jLhDkvI1BBfYD3JDLUZfN7opCxAHgCKlqnlVUY0tbpKrRWUgvrfR6O6qe1DhIusqAThVhLApKkk2gA5B1zNtK1EUUVoumGUMiGDuSuk8VX5SDqVqmeuAuYqz1xFI_RieOe8z99xKfVzx38Fzsa2MJvKJd8ebtxFEkEUuH2Z8ggdOCkZ_tbR-h-a9osKeq8KZimnmZG6EMwkRksmK4ALBmZFF1JHaHcjHCpYj079lIwIPR0eg967YI6ubbNyNEQC2AP0FaEHvUgOPYGv4EzSFIYjtoR1q6vbT-rFqc8tzl1GvoRF6OVGrH_p1j_n7dHlo3iMrpNe4cDr76LRsl3ZJ-iq-bZcdO0E7Yi58K2cBP2d-KURaI9J7loB7Th_d5x__gERN1I-
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VBQQX3o9AASPBBYiatePYOSBUKFWrLiuECtqbcRyHrkSTNtkFLT-K38jYSRaWR289cNjDbiaR7f1m5nM8D4BHxTDmtsiTUGfMhDErTCilRnWPtJAsoyb3tfQ-jMR4LCeT9O0afO9zYVxYZW8TvaHOK-PekW8MUy5cKc2Uvzg6Dl3XKHe62rfQaGGxZxdfccvWPN_dwv_3MaXbr_df7YRdV4HQcElnYcwNY3HOdB5x5_xkYqjvCB6lhtkU-biO8gwngNwpTywvUqqZ1UVirWAM8YrPPQNn0Y4LF0ImJmL5TsedmsXDtMvNiZjcaNA_uhw2dAXoe1kcshX_NzDN3HTdAv5Gcf-M1PztuNZ7we3L_9v6XYFLHd8mm62CXIU1W16D820HzsV1KLds4VtkkOO5buOmPFRJ21m7IbrMSYVm9XD6zUm5shYV6k5DkOyTQxfNqOtaL8jBwqW-dUmtpCqImdbGt0bDu7zcu_FmcwPen8pkb8KgrEp7G0iWZoWg3EqKjDuRVBsU57hriLUtRFYEMOyBoUxXn921CfmsfJwAk6oFk0IwKQ8mxQJ4urznqK1OcqL0E4c3ha7U1riaypUWX35xHxoJqpDUyIQH8NKhcvlYJ-t_qOpPqrNqKost4yw1UmciNpHRMpYFkiGDq6IzqQNY78GoOtvYqJ9IDODh8jJaNXdUpUtbzZ0MlUhlkVsGcKtVgeVIcI-fSpbgdMSKcqwMdfVKOT3wldO5qzcYxQE869Xol2H9c93unDyLB3BhZ__NSI12x3t34SJtlR35zToMZvXc3oNz5sts2tT3vbUg8PG01esHw2ileQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jj9MwFLaGsogL-xIYwEhwAaKmXhLngNBAqRjNUFUIRnMzjmMzlZhkJmlB5afx63h2FijL3ObAoYc2L5Htfm9x_N77EHpkR4wbm8ehyqgOGbU6FEKBukcqETQjOve99PZ2k-lU7O-nsw30vauFcWmVnU30hjovtXtHPhylPHGtNFM-tG1axGw8eXF0HDoGKXfS2tFpNBDZMauvsH2rn2-P4b9-TMjk9ftXb8KWYSDUXJBFyLimlOVU5RF3jlDEmnh28CjV1KQQm6soz2AyEEflseE2JYoaZWNjEkoBu_DcM-hswjh32vWWzPr3O-4EjY3Stk4nomJYg6909WzgFsAPUxbSNV840PVSt8wBfwt3_8za_O3o1nvEyeX_eS2voEttHI63GsW5ijZMcQ2db5g5V9dRMTbWU2fg46Vq8qk8hHHDuF1jVeS4BHN7OP_mpFy7ixJ0qsawCcCHLstRVZVa4YOVK4lri11xabGeV9pTpsFdXu7ddKu-gT6cymRvokFRFuY2wlma2YRwIwhE4rEgSoM4h90EU8YmmQ3QqAOJ1G3fdkcf8ln6_AEqZAMsCcCSHliSBuhpf89R07XkROknDnsSXKypYDWlaznef3EfEiVEQrAjYh6glw6h_WOdrP-hrD7J1trJjBnKaaqFyhKmI60EExaCJA2rojKhArTZAVO2NrOWP1EZoIf9ZbB27ghLFaZcOhkiIMSFmDNAtxp16EcCe_9U0Bimk6wpytpQ168U8wPfUZ27PoQRC9CzTqV-GdY_1-3OybN4gC6AVsnd7enOXXSRNHoPYc8mGiyqpbmHzukvi3ld3feGA6OPp61dPwBnE65G
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Defining+quantification+methods+and+optimizing+protocols+for+microarray+hybridization+of+circulating+microRNAs&rft.jtitle=Scientific+reports&rft.au=Garcia-Elias%2C+Anna&rft.au=Alloza%2C+Leonor&rft.au=Puigdecanet%2C+Eul%C3%A0lia&rft.au=Nonell%2C+Lara&rft.date=2017-08-10&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=7&rft.spage=1&rft.epage=14&rft_id=info:doi/10.1038%2Fs41598-017-08134-3&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon